ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryRetail & CommerceWholesale - Chemical & Plastic ProductsZugStemline Therapeutics Switzerland GmbH
Stemline Therapeutics Switzerland GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Stemline Therapeutics Switzerland GmbH focuses on the development and commercialization of oncology therapeutics. The company is part of the Menarini Group and cites products and pipeline candidates such as ELZONRIS (tagraxofusp) and ORSERDU (elacestrant).

AI-generated
Offering

Products & services

Industry:Wholesale - Chemical & Plastic Products
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Stemline Therapeutics Switzerland GmbH

4
Oncology medicines
Oncology medicines for difficult-to-treat cancers, including ELZONRIS® (tagraxofusp-erzs), ORSERDU™ (elacestrant) and other therapies in development.
Clinical development of cancer medicines
Clinical development of active substances for haematological malignancies, breast cancer and other tumour types; includes preclinical programmes, clinical trials and regulatory development stages.
Expanded Access Programme
Pre-approval access to investigational medicines for patients who do not have a suitable clinical trial or a satisfactory alternative therapy, on request of the treating physician.
Business Development
Licensing, co-development and acquisition of additional drug candidates; leveraging drug development, manufacturing and commercialization expertise for partner solutions.
Trust & reputation

ranQ Trust Score of Stemline Therapeutics Switzerland GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Stemline Therapeutics Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Stemline Therapeutics Switzerland GmbH scores 72.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.75.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Stemline Therapeutics Switzerland GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Stemline Therapeutics Switzerland GmbH scores 100.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Stemline Therapeutics Switzerland GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Stemline Therapeutics Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Stemline Therapeutics Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Stemline Therapeutics Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Stemline Therapeutics Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Grafenaustrasse 3
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-166.416.225
Founded
2019 · 7 years
Last commercial register change
August 4, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.88.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    VI
    VWR International GmbH
    Zug
    ID
    International Distribution & Services Group AG
    Zug
    TH
    Tireca Handel GmbH
    Zug
    ID
    ICC Dover Chemical GmbH
    Zug
    AA
    Aglobis AG
    Zug
    ZG
    Zytomics GmbH (Schweiz)
    Zug
    CA
    Critarion AG
    Zug
    MT
    MRI Trading AG
    Zug